Novel dual-target FAAH and TRPV1 ligands as potential pharmacotherapeutics for pain management

Dual-acting drugs that simultaneously inhibit fatty acid amide hydrolase (FAAH) and antagonize the transient receptor potential vanilloid 1 (TRPV1) is a promising stronger therapeutic approach for pain management without side effects associated with single-target agents. Here, several series of dual...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	European journal of medicinal chemistry 2024-03, Vol.267, p.116208-116208, Article 116208
Hauptverfasser:	Qiao, Zhenrui, Liu, Shuyu, zhai, Weibin, Jiang, Lei, Ma, Yunmeng, Zhang, Zhikang, Wang, Bingxin, Shao, Jingwen, Qian, Hai, Zhao, Fenqin, Yan, Lin
Format:	Artikel
Sprache:	eng
Schlagworte:	Analgesic Fatty acid amide hydrolase Side effect Transient receptor potential vanilloid type 1
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!